The role of advanced glycation end products (AGEs) and the receptor for AGEs (RAGE) in hypertrophic obstructive cardiomyopathy. [PDF]
Li S, Bi X, An Q, Li Y, Tang Y.
europepmc +1 more source
Cardiac myosin inhibitors: Efficacy, safety and future directions of aficamten in hypertrophic obstructive cardiomyopathy. [PDF]
Ogieuhi IJ +14 more
europepmc +1 more source
Early Detection of Treatment Response to Mavacamten in Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Regurgitation Using Magnetocardiography. [PDF]
Suwalski P +4 more
europepmc +1 more source
Integrated efficacy and safety analysis of mavacamten monotherapy in patients with obstructive hypertrophic cardiomyopathy [PDF]
Iacopo Olivotto +9 more
openalex +1 more source
Structural and Functional Characterization of the Aorta in Hypertrophic Obstructive Cardiomyopathy. [PDF]
Ibrahim AM +13 more
europepmc +1 more source
Mid-term results of the floating stitch for systolic anterior motion in hypertrophic obstructive cardiomyopathy. [PDF]
Uemura T +4 more
europepmc +1 more source
Case 01/2008: a young female patient with the familial form of hypertrophic cardiomyopathy, who evolved with syncope, complex ventricular arrhythmia and cardiogenic shock [PDF]
ARTEAGA, Edmundo +4 more
core +2 more sources
Comparison of plasma metabolic profiling between children with hypertrophic obstructive cardiomyopathy and healthy controls. [PDF]
Dong S +9 more
europepmc +1 more source

